Cargando…

Regulation of p53 by Helicobacter pylori

Detalles Bibliográficos
Autores principales:	Zaika, Alexander, Wei, Jinxiong, Noto, Jennifer, Peek, Richard M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717956/ https://www.ncbi.nlm.nih.gov/pubmed/23165367

Ejemplares similares

Helicobacter pylori bacteria alter the p53 stress response via Erk-HDM2 pathway
por: Bhardwaj, Vikas, et al.
Publicado: (2015)

Microbial Regulation of p53 Tumor Suppressor
por: Zaika, Alexander I., et al.
Publicado: (2015)

Helicobacter pylori pathogen regulates p14ARF tumor suppressor and autophagy in gastric epithelial cells
por: Horvat, Andela, et al.
Publicado: (2018)

p53 Family: Role of Protein Isoforms in Human Cancer
por: Wei, Jinxiong, et al.
Publicado: (2012)

Special issue: Helicobacter pylori
por: Peek, Richard M
Publicado: (2013)

The Role of microRNAs in Helicobacter pylori Pathogenesis and Gastric Carcinogenesis
por: Noto, Jennifer M., et al.
Publicado: (2012)

Helicobacter pylori pathogen inhibits cellular responses to oncogenic stress and apoptosis
por: Palrasu, Manikandan, et al.
Publicado: (2022)

The gastric microbiome, its interaction with Helicobacter pylori, and its potential role in the progression to stomach cancer
por: Noto, Jennifer M., et al.
Publicado: (2017)

Helicobacter pylori Perturbs Iron Trafficking in the Epithelium to Grow on the Cell Surface
por: Tan, Shumin, et al.
Publicado: (2011)

Proinflammatory Cytokines and Bile Acids Upregulate ΔNp73 Protein, an Inhibitor of p53 and p73 Tumor Suppressors
por: Zaika, Elena, et al.
Publicado: (2013)

"Targeted disruption of the epithelial-barrier by Helicobacter pylori"
por: Wroblewski, Lydia E, et al.
Publicado: (2011)

Helicobacter pylori actively suppresses innate immune nucleic acid receptors
por: Dooyema, Samuel D.R., et al.
Publicado: (2022)

Helicobacter pylori Infection
por: Hsu, Ping-I, et al.
Publicado: (2015)

Helicobacter pylori and Pathogenesis
por: Tomoda, Akio, et al.
Publicado: (2015)

Helicobacter pylori genetic diversification in the Mongolian gerbil model
por: Beckett, Amber C., et al.
Publicado: (2018)

Helicobacter pylori and Systemic Disease
por: Kuo, Chao-Hung, et al.
Publicado: (2014)

Recent advances in Helicobacter pylori eradication
por: Niv, Yaron, et al.
Publicado: (2015)

Modification of the Gastric Mucosal Microbiota by a Strain-Specific Helicobacter pylori Oncoprotein and Carcinogenic Histologic Phenotype
por: Noto, Jennifer M., et al.
Publicado: (2019)

Sound the Alarmin: Interleukin-33 Commandeers the Gastric Immune Response
por: Noto, Jennifer M., et al.
Publicado: (2015)

RNF43: A Biomarker With Potential Ramifications for Therapeutic Intervention in Gastric Cancer
por: Noto, Jennifer M., et al.
Publicado: (2020)

Concurrent overexpression of serum p53 mutation related with Helicobacter pylori infection
por: Lopez-Saez, Juan-Bosco, et al.
Publicado: (2010)

Helicobacter pylori Infection and Upper Gastrointestinal Disorders
por: Kate, Vikram, et al.
Publicado: (2013)

Self-Medication With Analgesics and Helicobacter pylori Infection
por: Metanat, Maliheh
Publicado: (2015)

Helicobacter pylori infection and osteoporosis in elderly patients
por: Heidari, Behzad
Publicado: (2015)

Helicobacter pylori: Infection and New Perspective for the Treatment
por: Fasciana, Teresa, et al.
Publicado: (2019)

Strategies for Helicobacter pylori eradication in the year 2020
por: Pellicano, Rinaldo, et al.
Publicado: (2020)

Inflammation at the crossroads of Helicobacter pylori and COVID-19
por: Gonzalez, Ileana, et al.
Publicado: (2021)

Role of Tegoprazan in Helicobacter pylori Eradication Therapy
por: Lee, Jin
Publicado: (2022)

p53, a potential predictor of Helicobacter pylori infection-associated gastric carcinogenesis?
por: Li, Nianshuang, et al.
Publicado: (2016)

Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments
por: Noto, Jennifer M, et al.
Publicado: (2018)

Helicobacter pylori and gastric cancer: time for mega-trials?
por: Danesh, J
Publicado: (1999)

23 years of the discovery of Helicobacter pylori: Is the debate over?
por: Ahmed, Niyaz
Publicado: (2005)

Glimpse of the Epidemiological Research on Helicobacter Pylori in Saudi Arabia
por: BinSaeed, Abdulaziz A.
Publicado: (2009)

Helicobacter pylori: Have potential benefits been overlooked?
por: Schubert, Jonathon P, et al.
Publicado: (2022)

Refractory Helicobacter pylori treatment in resource‐limited settings
por: Mahadeva, Sanjiv
Publicado: (2023)

In Vitro Characterization of the Anti-Bacterial Activity of SQ109 against Helicobacter pylori
por: Makobongo, Morris O., et al.
Publicado: (2013)

Functional Plasticity in the Type IV Secretion System of Helicobacter pylori
por: Barrozo, Roberto M., et al.
Publicado: (2013)

Loss of p53 Expression in Gastric Epithelial Cells of Helicobacter pylori-Infected Jordanian Patients
por: Abu-Lubad, Mohammad A., et al.
Publicado: (2022)

State of the globe: Diagnostic tests to detect Helicobacter pylori tonsillitis
por: Fazaeli, Asghar
Publicado: (2012)

Helicobacter pylori Has an Inverse Relationship With Severity of Reflux Esophagitis
por: Nam, Su Youn
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_56fl8fsn2roaak3ivmetgidho0